Active substance:
Complex of peptides

Brief description::
Cerabin-C contributes to the regression of focal neurological symptoms, thereby accelerating the recovery of patients


Additional information:

Drug indication:

  • ischemic stroke;
  • chronic cerebrovascular pathology;
  • traumatic brain injuries;
  • mental retardation in children;
  • disorders associated with attention deficit in children;
  • dementia syndromes of various origins;
  • Alzheimer's disease;
  • endogenous depression, resistant to antidepressants.

Drug effects: Cerabin-C activates regulatory genes responsible for the synthesis of protein molecules, has a neuroprotective effect, promotes the regeneration of neurons, contains low-molecular neuropeptides that pass through the BBB and directly enters the nerve cells

Composition: complex of peptides-215.2 mg;

Form of production: 5 ml of the solution in ampoules, in a package of 5 ampoules.